Jefferies Financial Group reaffirmed their buy rating on shares of Chemring Group (LON:CHG – Free Report) in a research report released on Tuesday morning, Marketbeat.com reports. Jefferies Financial Group currently has a GBX 470 ($5.98) price objective on the stock.
Chemring Group Trading Down 13.0 %
Shares of CHG opened at GBX 314.50 ($4.00) on Tuesday. The company has a current ratio of 1.27, a quick ratio of 0.71 and a debt-to-equity ratio of 22.77. Chemring Group has a 1-year low of GBX 309.01 ($3.93) and a 1-year high of GBX 428 ($5.44). The stock has a market capitalization of £852.36 million, a P/E ratio of 2,859.09, a P/E/G ratio of 1.99 and a beta of 0.68. The business’s 50-day moving average price is GBX 360.54 and its 200 day moving average price is GBX 377.70.
Chemring Group Increases Dividend
The company also recently disclosed a dividend, which will be paid on Friday, April 11th. Investors of record on Thursday, March 20th will be given a dividend of GBX 5.20 ($0.07) per share. This is a boost from Chemring Group’s previous dividend of $2.60. The ex-dividend date is Thursday, March 20th. This represents a yield of 1.44%. Chemring Group’s dividend payout ratio (DPR) is presently 6,363.64%.
Insider Activity at Chemring Group
Chemring Group Company Profile
Chemring Group PLC provides countermeasures, sensors, information, and energetic products in the United States, the United Kingdom, Europe, the Asia pacific, and internationally. The company offers sensors and information products, such as point chemical detector, sensor, JSLSCAD, and I-SCAD; miniature radar altimeter, R Visor, 3D radars, husky mounted detection system, groundshark, MDS-10, and groundhunters; resolve, locate, LOCATE-T, and viper products; and advisory, research, and design and engineering services.
Further Reading
- Five stocks we like better than Chemring Group
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- AppLovin Insiders Sell Shares: Stock Price Indicated Higher
- Want to Profit on the Downtrend? Downtrends, Explained.
- Broadcom’s Stellar Outlook Sparks Hopes for a Semi Sector Rally
- Health Care Stocks Explained: Why You Might Want to Invest
- Salesforce’s Clear Path to $400 and Beyond
Receive News & Ratings for Chemring Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemring Group and related companies with MarketBeat.com's FREE daily email newsletter.